Corneal Disease Clinical Trial
Official title:
Study of Automated Lamellar Keratectomy With a New Option in Treatment in Symptomatic Patients With Bullous Keratopathy.
To relieve pain in patients with symptomatic bullous keratopathy (BK) until keratoplasty and
in patients without visual prediction.
The automated lamellar keratectomy represents a alternative in treatment of pain in
symptomatic patients with BK.
Only patients with BK symptomatic (with pain) were submitted to automated lamellar
keratectomy (ALK).
Complete ophthalmological examination including UCVA,BSVA, biomicroscopy, tonometry,
esthesiometry, UBM pachymetry, impression cytology and pain questionnaire were performed in
preoperative, postoperative of one, seven, 30, 90, 180 days and one year.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05114928 -
Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
|
||
| Recruiting |
NCT06160960 -
Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome
|
||
| Completed |
NCT00357435 -
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
|
||
| Completed |
NCT04484402 -
Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05581875 -
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06101017 -
Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
|
||
| Withdrawn |
NCT03421548 -
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
|
N/A | |
| Withdrawn |
NCT05700864 -
NGF Treatment for Patients With Neuropathic Corneal Pain
|
Phase 1 | |
| Enrolling by invitation |
NCT05758753 -
QST for Corneal Nerve Function
|
N/A | |
| Terminated |
NCT00001310 -
Tissue Studies of Human Eye Diseases
|
||
| Completed |
NCT02386774 -
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
|
N/A | |
| Recruiting |
NCT05694247 -
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
|
N/A | |
| Not yet recruiting |
NCT06294015 -
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.
|
Phase 4 | |
| Recruiting |
NCT04251143 -
Dresden Corneal Disease and Treatment Study
|
||
| Withdrawn |
NCT02374723 -
Evaluation of Biosynthetic Constructs to Replace Donor Corneas
|
Phase 1 | |
| Completed |
NCT01384487 -
Nidek RS3000 Comparative Study
|
N/A | |
| Completed |
NCT00804505 -
Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study
|
N/A | |
| Completed |
NCT04475900 -
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
|
||
| Recruiting |
NCT05573802 -
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
|
Phase 1/Phase 2 | |
| Terminated |
NCT04485858 -
First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness
|
N/A |